During the past decade, Cooper CyberKnife Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cooper CyberKnife Center" #1 collaborator was "NRG Oncology" with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cooper CyberKnife Center" are "Advanced Vaginal Adenocarcinoma" (1 trials), "Advanced Vaginal Adenosquamous Carcinoma" (1 trials), "Advanced Vaginal Squamous Cell Carcinoma" (1 trials), "Cervical Adenocarcinoma" (1 trials) and "Cervical Adenosquamous Carcinoma" (1 trials). Many other conditions were trialed in "Cooper CyberKnife Center" in a lesser frequency.

Most popular intervention types in "Cooper CyberKnife Center" are "Radiation" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Brachytherapy" (1 trials), "Cisplatin" (1 trials), "External Beam Radiation Therapy" (1 trials) and "Intensity-Modulated Radiation Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cooper CyberKnife Center" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cooper CyberKnife Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cooper CyberKnife Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cooper CyberKnife Center, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".